IP Library Granted Patent US 12,453,498
Granted Patent B2
US 12,453,498 · App. 18/114,018 · Granted Oct 28, 2025

Devices and methods for verifying a sample volume

Inventors: Gregory J. Bullington (Seattle, WA); Shan E. Gaw (Seattle, WA); Jay M. Miazga (Langley, WA); Shannon E. Eubanks (Woodinville, WA)
Assignee: Magnolia Medical Technologies, Inc.
A61B5/157A61B5/15003A61B5/150755A61B5/150992A61B5/154A61B10/0045A61B5/150786
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,453,498
App. No.
18/114,018
Granted
Oct 28, 2025
Kind
B2
Abstract

A system for verifying a sample volume includes a sample reservoir and a volumetric verification device. The sample reservoir defines an inner volume and is configured to receive a volume of bodily fluid. The inner volume of the sample reservoir contains an additive. The volumetric verification device includes a first indicator and a second indicator. The volumetric verification device is configured to selectively engage the sample reservoir to (1) place the first indicator in a first position along a length of the sample reservoir such that the first indicator is substantially aligned with a surface and/or meniscus of the additive and (2) place the second indicator in a second position along the length of the sample reservoir such that the second indicator is substantially aligned with a predetermined fill volume when bodily fluid is transferred to the inner volume.

Claims (23)

1. An apparatus, comprising:

a sleeve having an open proximal end portion and an open distal end portion, the sleeve having an inner surface defining an inner volume, the sleeve configured to be movably fitted around an exterior surface of a sample reservoir defining an inner volume configured to receive a volume of bodily fluid; and

an indicator coupled to or formed at least in part by the sleeve,

the sleeve when coupled to the sample reservoir configured to place the indicator in a predetermined position along a length of the sample reservoir, the predetermined position being associated with a predetermined fill volume of bodily fluid based at least in part on an additive contained in the inner volume of the sample reservoir.

2. The apparatus of claim 1 , wherein the indicator being placed in the predetermined position along the length of the sample reservoir when the sleeve is disposed about the sample reservoir places the indicator in a position along indicia on a label of the sample reservoir representing a fill volume of the sample reservoir.

3. The apparatus of claim 2 , wherein the indicator is a marker coupled to the inner surface of the sleeve, the marker is configured to produce a mark at the position along the indicia when the sleeve is disposed about the sample reservoir and a force is exerted on a portion of the sleeve that is coupled to the marker.

4. The apparatus of claim 3 , wherein the mark is at least one of a colored line, a score, a scrape, or an indentation at the predetermined position along the length of the sample reservoir.

5. The apparatus of claim 1 , wherein the additive is one of an aerobic culture medium or an anaerobic culture medium.

6. The apparatus of claim 1 , wherein the predetermined fill volume is a first predetermined fill volume when the sample reservoir contains a first additive, and

the predetermined fill volume is a second predetermined fill volume different from the first predetermined fill volume when the sample reservoir contains a second additive different from the first additive.

7. The apparatus of claim 1 , wherein a total predetermined fill volume within the sample reservoir is a combination of a first volume corresponding to the additive and a second volume corresponding to the bodily fluid.

8. An apparatus, comprising:

a sleeve having an open proximal end portion and an open distal end portion, the sleeve having an inner surface defining an inner volume, the sleeve configured to be movably fitted around an exterior surface of a sample reservoir defining an inner volume configured to receive a volume of bodily fluid, the inner volume of the sample reservoir containing an additive; and

a first indicator and a second indicator, each of the first indicator and the second indicator coupled to or formed at least in part by the inner surface of the sleeve,

the sleeve when coupled to the sample reservoir configured to (i) place the first indicator in a first position along a length of the sample reservoir associated with a surface of the additive and (ii) place the second indicator in a second position along the length of the sample reservoir associated with a predetermined fill volume when bodily fluid is transferred to the inner volume, the predetermined volume based at least in part on the additive contained in the inner volume of the sample reservoir.

9. The apparatus of claim 8 , wherein the additive is one of an aerobic culture medium or an anaerobic culture medium.

10. The apparatus of claim 9 , wherein the predetermined fill volume is a first predetermined fill volume when the sample reservoir contains the aerobic culture medium, and

the predetermined fill volume is a second predetermined fill volume different from the first predetermined fill volume when the sample reservoir contains the anaerobic culture medium.

11. The apparatus of claim 8 , wherein the second indicator in the second position is substantially aligned with the surface of the additive and the first indicator in the first position is substantially aligned with the predetermined fill volume of bodily fluid when bodily fluid is transferred to the inner volume of the sample reservoir.

12. The apparatus of claim 8 , wherein the first indicator is a first window formed by the sleeve and the second indicator is a second window formed by the sleeve.

13. The apparatus of claim 8 , wherein the first indicator is configured to produce a first mark at the first position along the length of the sample reservoir that is substantially aligned with the predetermined fill volume of bodily fluid, and

the second indicator is configured to produce a second mark at the second position along the length of the sample reservoir that is substantially aligned with the surface of the additive.

14. The apparatus of claim 8 , wherein the first position along the length of the sample reservoir is separated from the second position along the length of the sample reservoir by a distance, a volume of the additive disposed in the inner volume of the sample reservoir is equal to a volume of a portion of the inner volume of the sample reservoir between the first position and the second position.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Jan 2, 2024
From: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 066178/0969 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2023
From: BULLINGTON, GREGORY J.; GAW, SHAN E.; MIAZGA, JAY M.; EUBANKS, SHANNON E.
To: MAGNOLIA MEDICAL TECHNOLOGIES, INC.
Reel/Frame 063728/0513 →
Continuity (4)
Continuation 16227676 · Dec 20, 2018
Continuation 15146967 · May 5, 2016
Provisional Application 62157145 · May 5, 2015
Related Publication 20240050001A1 · Feb 15, 2024
References Cited (24)
US 3696806A · Sausse et al. · 1972 [cited by applicant]
US 5809674A · Key · 1998 [cited by applicant]
US 9003879B1 · Honan et al. · 2015 [cited by applicant]
US 20040147878A1 · Lyon et al. · 2004 [cited by applicant]
US 20050277848A1 · Graf · 2005 [cited by applicant]
US 20080125673A1 · Carano · 2008 [cited by examiner]
US 20090053111A1 · Francis · 2009 [cited by applicant]
US 20110042255A1 · Traboulsi et al. · 2011 [cited by applicant]
US 20140193848A1 · Kaufman · 2014 [cited by applicant]
US 20150094615A1 · Patton · 2015 [cited by applicant]
US 20160324454A1 · Bullington et al. · 2016 [cited by applicant]
US 20190142319A1 · Bullington et al. · 2019 [cited by applicant]
WO WO2008031036A1 · 2008 [cited by applicant]
WO WO2016179347A1 · 2016 [cited by applicant]
Extended European Search Report for European Application No. EP20230177210 dated Nov. 7, 2023, 9 pages. [cited by applicant]
Extended European Search Report for EP Application No. 16790058.8, dated Sep. 3, 2018, 9 pages. [cited by applicant]
Extended European Search Report for EP Application No. 19211307.4, dated Mar. 18, 2020, 8 pages. [cited by applicant]
Extended European Search Report for EP Application No. 21184923.7, dated Dec. 23, 2021, 5 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/227,676, dated May 10, 2022, 10 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2016/030888, dated Aug. 12, 2016, 12 pages. [cited by applicant]
Office Action for U.S. Appl. No. 15/146,967, dated Mar. 22, 2018, 10 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/227,676, dated Nov. 30, 2022, 8 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/227,676, dated Sep. 15, 2021, 13 pages. [cited by applicant]
Patel, R. et al., “Optimized Pathogen Detection with 30- Compared to 20-Milliliter Blood Culture Draws.” Journal of Clinical Microbiology, 49(12):4047-4051 (2011). [cited by applicant]